medigraphic.com
SPANISH

Revista Cubana de Medicina Militar

ISSN 1561-3046 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 4

<< Back Next >>

Rev Cub Med Mil 2020; 49 (4)

Clinical prognostic factors determining the survival of patients with the Ebola virus

Miranda GO, Castro BCM, Fleites AYA, Díaz GJE, Contreras OY, Urgellés CSA
Full text How to cite this article

Language: Spanish
References: 19
Page:
PDF size: 314.76 Kb.


Key words:

ebolavirus, hemorragic fever ebola, lethality, ebolavirus disease.

ABSTRACT

Introduction: Ebola virus disease has a high lethality, which is why it is of great interest to carry out research that addresses clinical manifestations that could be prognostic factors for survival.
Objective: To evaluate prognostic factors of Ebola patients.
Methods: the universe was constituted by the totality (n = 350) of admitted patients. Summary measures were used for qualitative variables, point and interval estimates for quantitative variables, as well as Kaplan-Meier significance tests, Cox regression and Odds Ratio. We worked with a 95% level of reliability.
Results: The overall survival was 42.5%. The average survival, approximately 10 days (CI: 9-11 days). Patients who were admitted in serious condition (OR = 3.76), who had low back pain (OR = 2.24), who reported headache (OR = 2.22), who presented fever (OR = 2.16), who they suffered from abdominal pain (OR = 1.95) and who were found to have conjunctival injection (OR = 1.86), were more likely to die than those who entered without these symptoms and signs.
Conclusions: Survival was high, despite the complications presented. The symptoms and predictive signs of death in the patients were: the severity of the patient at admission, the presence of low back pain, headache, fever, abdominal pain and conjunctival injection.


REFERENCES

  1. Maguiña Vargas C. Enfermedad por el virus del Ébola. Rev Med Hered. Jul 2015 [acceso: 12/03/2019];26(3):195-201. Disponible en: http://www.scielo.org.pe/scielo.php?pid=S1018-130X2015000300010&script=sci_arttext

  2. Organización Panamericana de la Salud. Enfermedad por el virus del Ébola, implicaciones de la introducción en las Américas. Washington: Organización Panamericana de la Salud; 2014. [acceso: 12/03/2019]. Disponible en: Disponible en: http://www2.paho.org/hq/index.php?option=com_docman&task=doc_view&gid=26414+&Itemid=270&lang=es

  3. World Health Organization. Ebola hemorrhagic fever in Zaire. Informe de una comisión internacional. Bull World Health Organ. 1978 [acceso: 12/03/2019];56(2):271-93. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395567/

  4. Enfermedad por el virus del Ebola. Ginebra: Organización Mundial de la Salud; 2015[actualizado: 10/02/2020; acceso: 12/03/2020]. Notas descriptivas [aprox. 15 pant.]. Disponible en: Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/ebola-virus-disease

  5. Qureshi AI. Ebola Virus Disease: From Origin to Outbreak. En: Qureshi AI. Clinical Manifestations and Laboratory Diagnosis of Ebola Virus Infection. Amsterdam: Elsevier Inc. 2016;117-138. [acceso: 12/03/2019]. Disponible en: http://www.sciencedirect.com/science/article/pii/B9780128042304000091

  6. Annette M, Poirson JM, Zingeser J, Otto P, de Balogh K, Boulet H. La enfermedad por el virus del Ébola en el África Occidental: una emergencia de salud pública que se transforma en una crisis compleja. Unasylva. 2015 [acceso: 12/03/2019];66(243-244):67-78. Disponible en: http://www.fao.org/3/a-i4447s.pdf

  7. Kolbach M, Carrasco-Zubera JE, Vial-Letelier V. Ébola: caracterización, historia y manifestaciones cutáneas; lo que debemos saber. Rev Med Chile. 2015 [acceso: 12/03/2019];143:1444-48. Disponible en: https://scielo.conicyt.cl/scielo.php?pid=S0034-98872015001100010&script=sci_arttext

  8. Sánchez Serrano LP. Brote de Fiebre Hemorrágica por Virus Ébola en Uganda. Boletín Epidemiológico Semanal de España. 2000[acceso: 12/03/2019];8(14):145-56. Disponible en: http://gesdoc.isciii.es/gesdoccontroller?action=download&id=22/04/2013-3ef20882ad

  9. Khan AS, Tshioko FK, Heymann DL, Le Guenno B, Nabeth P, Kerstiëns B, et al. The Reemergence of Ebola Hemorrhagic Fever, Democratic Republic of the Congo, 1995. J Infect Dis. 1999 [acceso: 12/03/2019];179(Supl. 1):s76-85. Disponible en: Disponible en: https://academic.oup.com/jid/article-lookup/doi/10.1086/514306

  10. Ávila Agüero ML. Ébola: Una amenaza global. Acta Méd Costarric. 2014 [acceso: 12/03/2019];56(4):1-6. Disponible en: https://www.scielo.sa.cr/scielo.php?script=sci_arttext&pid=S0001-60022014000400002

  11. Case Definition for Ebola Virus Disease (EVD). Atlanta: Centers for Disease Control and Prevention; 2015 [actualizado: 09/07/2019; acceso: 11/10/2019]. Screening Patients. Disponible en: Disponible en: https://www.cdc.gov/vhf/ebola/clinicians/evaluating-patients/case-definition.html

  12. Asociación Médica Mundial. Declaración de Helsinki de la Asociación Médica Mundial - Principios éticos para las investigaciones médicas en seres humanos. Universidad de Navarra: Centro de Documentación de Bioética. Departamento de Humanidades Biomédicas; 2013.

  13. World Health Organization. World Health Statistics 2016. Monitoring health for the SDGs (Sustainable Development Goals). Geneva: World Health Organization; 2016.

  14. Schieffelin JS, Shaffer JG, Goba A, Gbakie M, Gire SK, Colubri A, et al. Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone. N Engl J Med. Nov 2014 [acceso: 12/03/2019];371:2092-2100. Disponible en: http://www.nejm.org/doi/full/10.1056/NEJMoa1411680#t=article

  15. Ying-Jie J, Xue-Zhang D, Xu-Dong G, Lei L, Chen L, Dong J, et al. Clinical presentations and outcomes of patients with Ebola virus disease in Freetown, Sierra Leone. Infectious Diseases of Poverty. 2016 [acceso: 12/03/2019];5(101):[aprox. 10 pant.]. Disponible en: https://idpjournal.biomedcentral.com/articles/10.1186/s40249-016-0195-9

  16. Qureshi AI, Chughtai M, Bah EI, Barry M, Béavogui K, Loua TO, et al. High Survival Rates and Associated Factors Among Ebola Virus Disease Patients Hospitalized at Donka National Hospital, Conakry, Guinea. J Vasc Interv Neurol. 2015 [acceso: 12/03/2019];8(1.5):s4-s11. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434807/

  17. Zhong-Jie L, Wen-Xiao T, Xiao-Chun W, Guo-Qing S, Zun-Dong Y, Hai-Jun S, et al. A practical community-based response strategy to interrupt Ebola transmission in Sierra Leone, 2014-2015. Infectious Diseases of Poverty. 2016 [acceso: 12/03/2019];5(74):[aprox. 10 pant.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974705/

  18. Ajelli M, Parlamento S, Bome D, Kebbi A, Atzori A, Frasson C, et al. The 2014 Ebola virus disease outbreak in Pujehun, Sierra Leone: epidemiology and impact of interventions. BMC Medv. 2015 [acceso: 12/03/2019];13(281):[aprox. 8 pant]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660799/

  19. Bwaka MA, Bonnet MJ, Calain P, Colebunders R, De Roo A, Guimard Y, et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis. 1999 [acceso: 12/03/2019];179(Suppl. 1):s1-7. Disponible en: https://academic.oup.com/jid/article/179/Supplement_1/S1/879641/Ebola-Hemorrhagic-Fever-in-Kikwit-Democratic




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cub Med Mil . 2020;49